Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?

被引:4
|
作者
Oh, Joo Hyun [1 ]
Sinn, Dong Hyun [2 ,3 ]
机构
[1] Eulji Univ, Nowon Eulji Med Ctr, Dept Med, Sch Med, Daejeon, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
关键词
Hepatitis B; chronic; Biopsy; Fibrosis; CORE-RELATED ANTIGEN; MANAGEMENT; GUIDELINES; INFECTION;
D O I
10.3350/cmh.2023.0054
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:367 / 370
页数:4
相关论文
共 50 条
  • [41] Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
    Kawanaka, Miwa
    Nishino, Ken
    Kawamoto, Hirofumi
    Haruma, Ken
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (43) : 7497 - 7508
  • [42] Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States
    Pak, Kevin
    Sachar, Ryan
    Saab, Sammy
    DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (04) : 1547 - 1554
  • [43] Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
    Jeon, Mi Young
    Kim, Beom Kyung
    Lee, Jae Seung
    Lee, Hye Won
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seung Up
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (02) : 295 - 304
  • [44] Noninvasive models to predict liver cirrhosis inpatients with chronic hepatitis B
    Kim, Beom Kyung
    Kim, Sung Ae
    Park, Young Nyun
    Cheong, Jae Youn
    Kim, Hwa Sook
    Park, Jun Yong
    Cho, Sung Won
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Moon, Young Myoung
    Ahn, Sang Hoon
    LIVER INTERNATIONAL, 2007, 27 (07) : 969 - 976
  • [45] "To Be or Not to Be": Immune Tolerance in Chronic Hepatitis B
    Protzer, Ulrike
    Knolle, Percy
    GASTROENTEROLOGY, 2016, 151 (05) : 805 - 806
  • [46] Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase"
    Chu, Chia -Ming
    Liaw, Yun-Fan
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (02) : 510 - 512
  • [47] Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
    Myers, RP
    Tainturier, MH
    Ratziu, V
    Piton, A
    Thibault, V
    Imbert-Bismut, F
    Messous, D
    Charlotte, F
    Di Martino, V
    Benhamou, Y
    Poynard, T
    JOURNAL OF HEPATOLOGY, 2003, 39 (02) : 222 - 230
  • [48] SPECIFIC FEATURES OF LYMPHOID INFILTRATION IN LIVER BIOPSY IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C
    Umbetova, K. T.
    Lazareva, A. S.
    Kiselevsky, M. V.
    Parkhomenko, Yu. G.
    Volchkova, E. V.
    Pak, S. G.
    TERAPEVTICHESKII ARKHIV, 2011, 83 (11) : 31 - 33
  • [49] Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels
    Xie, Yao
    Yi, Wei
    Zhang, Lu
    Lu, Yao
    Hao, Hong-Xiao
    Gao, Yuan-Jiao
    Ran, Chong-Ping
    Lu, Hui-Hui
    Chen, Qi-Qi
    Shen, Ge
    Wu, Shu-Ling
    Chang, Ming
    Ping-Hu, Lei
    Liu, Rui-Yu
    Sun, Lei
    Wan, Gang
    Li, Ming-Hui
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 : 42 - 49
  • [50] Alanine aminotransferase course, serum hepatitis B virus DNA, and liver stiffness measurement for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B
    Charatcharoenwitthaya, Phunchai
    Phisalprapa, Pochamana
    Pausawasdi, Nonthalee
    Rungkaew, Pimpattana
    Kajornyuthidej, Sorrayut
    Bandidniyamanon, Wimolrak
    Chotiyaputta, Watcharasak
    Chainuvati, Siwaporn
    Tanwandee, Tawesak
    HEPATOLOGY RESEARCH, 2016, 46 (13) : 1347 - 1357